Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration
暂无分享,去创建一个
Teruo Okano | Akira Marui | Tatsuya Shimizu | Tadashi Ikeda | T. Okano | Tatsuya Shimizu | H. Masumoto | Hiroyuki Fukushima | R. Sakata | J. Yamashita | Masafumi Takeda | Hidetoshi Masumoto | Takeshi Ikuno | Shiori Katayama | Ryuzo Sakata | Jun K. Yamashita | T. Ikeda | Hiroyuki Fukushima | Masafumi Takeda | A. Marui | Shiori Katayama | T. Ikuno
[1] J. Barendregt,et al. Global burden of disease , 1997, The Lancet.
[2] S. Nishikawa,et al. Prospective identification of cardiac progenitors by a novel single cell‐based cardiomyocyte induction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] Lauran R. Madden,et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering , 2010, Proceedings of the National Academy of Sciences.
[4] Jun Yamashita,et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors , 2000, Nature.
[5] R. Weisel,et al. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. , 2001, The Annals of thoracic surgery.
[6] T. Ichisaka,et al. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells , 2013, Proceedings of the National Academy of Sciences.
[7] T. Okano,et al. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). , 1993, Journal of biomedical materials research.
[8] I. Weissman,et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies , 2013, Nature Medicine.
[9] T. Ichisaka,et al. Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .
[10] H. Laborit,et al. [Experimental study]. , 1958, Bulletin mensuel - Societe de medecine militaire francaise.
[11] Tatsuya Shimizu,et al. Enhanced Survival of Transplanted Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes by the Combination of Cell Sheets With the Pedicled Omental Flap Technique in a Porcine Heart , 2013 .
[12] Larry Kedes,et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. , 2002, Journal of molecular and cellular cardiology.
[13] Hideki Uosaki,et al. Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells , 2008, Circulation.
[14] D. Shum-Tim,et al. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. , 2006, The Journal of thoracic and cardiovascular surgery.
[15] H. Fujita,et al. Thoracic and cardiovascular surgery in Japan during 2003: annual report by The Japanese Association for Thoracic Surgery. , 2005, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[16] Lila R Collins,et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.
[17] Shinya Yamanaka,et al. Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression , 2011, PloS one.
[18] M. Rota,et al. Regenerating new heart with stem cells. , 2013, The Journal of clinical investigation.
[19] Teruo Okano,et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. , 2009, The Journal of clinical investigation.
[20] H. Masumoto,et al. Cardiovascular surgery for realization of regenerative medicine , 2012, General Thoracic and Cardiovascular Surgery.
[21] E. Ford,et al. Proportion of the decline in cardiovascular mortality disease due to prevention versus treatment: public health versus clinical care. , 2011, Annual review of public health.
[22] Yasuko Matsumura,et al. A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.
[23] Teruo Okano,et al. Pluripotent Stem Cell‐Engineered Cell Sheets Reassembled with Defined Cardiovascular Populations Ameliorate Reduction in Infarct Heart Function Through Cardiomyocyte‐Mediated Neovascularization , 2012, Stem cells.
[24] J. Thomson,et al. Embryonic stem cell lines derived from human blastocysts. , 1998, Science.
[25] Takashi Daimon,et al. Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.
[26] Mitsuo Umezu,et al. In Vitro Engineering of Vascularized Tissue Surrogates , 2013, Scientific Reports.
[27] M. Komeda,et al. Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study , 2002, Circulation.
[28] C. Don,et al. Improving survival and efficacy of pluripotent stem cell–derived cardiac grafts , 2013, Journal of cellular and molecular medicine.
[29] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[30] Brigitte Harris,et al. Benefits and Barriers , 2015 .
[31] A. Hatzopoulos,et al. Stem cell therapy for cardiac repair: benefits and barriers , 2009, Expert Reviews in Molecular Medicine.